Screening test validated for depression in adolescents

	Tweet

Primary-care clinicians know teen depression is common, but they’ve lacked a reliable screening test for it. Now researchers at the University of Washington (UW), Seattle Children’s, and Group Health report the PHQ-9 (Patient Health Questionnaire - 9 item) is a good screening test for major depression in adolescents.

Led by Laura P. Richardson, MD, MPH, the team tested the PHQ-9 as a screening tool for depression in 442 teenage patients, age 13-17, at Group Health. The test is brief, available free of charge, easy to score and understand, and proven to find major depression (meeting DSM-IV criteria) in adults. This study, the first to assess it in teens, is in the November 2010 Pediatrics.

“This is important not only because depression is relatively common among adolescents, but also because we have effective treatment for them,” said Dr. Richardson. She is an associate professor of pediatrics at the UW, an adolescent medicine specialist at Seattle Children’s, and an affiliate investigator at Group Health Research Institute. “Primary care clinicians are advised to screen teens for depression,” she said, “and they need a convenient tool like this.”

The team compared the PHQ-9 to the more labor-intensive gold standard, an independent structured mental health interview (the Child Diagnostic Interview Schedule, DISC-IV)—and to published data on use of the screening test in adults. They found the best cut point for maximizing the PHQ-9 screening test’s sensitivity without losing specificity (11) is higher among teens than in adults. But its sensitivity (89.5%) and specificity (77.5%) in teens are similar to those in adults. So the team concluded that the PHQ-9 is an excellent choice for providers and researchers who want to screen for depression in teens in primary care.

###

Reporters can request the full text of this article by contacting Debbie Linchesky at (847-434-7084), or Susan Martin at (847-434-7131).

UW Medicine

The UW Medicine health system includes UW Medical Center, Harborview Medical Center, Northwest Hospital, the UW School of Medicine, UW Medicine Neighborhood Clinics, UW Physicians, Airlift Northwest, and the UW’s partnership in the Seattle Cancer Care Alliance with Seattle Children’s and Fred Hutchinson Cancer Research Center. UW Medicine has major academic and service affiliations with Seattle Children’s Hospital, Fred Hutchinson Cancer Research Center, and the Veteran’s Affairs Puget Sound Health Care System in Seattle and the VA Hospital in Boise. The UW School of Medicine is the top public institution for biomedical research in funding received from the National Institutes of Health. For more information about UW Medicine, visit http://www.uwmedicine.org.

Seattle Children’s Hospital

Consistently ranked as one of the best children’s hospitals in the country by U.S. News & World Report, Children’s serves as the pediatric and adolescent academic medical referral center for the largest landmass of any children’s hospital in the country (Washington, Alaska, Montana and Idaho). For more than 100 years, Children’s has been delivering superior patient care and advancing new treatments through pediatric research. Children’s serves as the primary teaching, clinical and research site for the Department of Pediatrics at the University of Washington School of Medicine. The hospital works in partnership with Seattle Children’s Research Institute and Seattle Children’s Hospital Foundation. Together they are Seattle Children’s, known for setting new standards in superior patient care for more than 100 years. For more information visit http://www.seattlechildrens.org.

Group Health Research Institute

Founded in 1947, Group Health Cooperative is a Seattle-based, consumer-governed, nonprofit health care system. Group Health Research Institute (http://www.grouphealthresearch.org) changed its name from Group Health Center for Health Studies on September 8, 2009. Since 1983, the Institute has conducted nonproprietary public-interest research on preventing, diagnosing, and treating major health problems. Government and private research grants provide its main funding.

###

Contact: Rebecca Hughes

206-287-2055
Group Health Research Institute

RELATED STORIES:
Manic phase of bipolar disorder benefits from breast cancer medication   Newer Antidepressants Work 2 Ways   Trauma-induced changes to genes may lead to PTSD   Mental Health Needs of Soldiers Increase Several Months After Returning From Iraq War   Stress response predictor in police officers may indicate those at high risk for PTSD   Doubled risk of anxiety for 18 month-old children with congenital heart defects   Valproic acid may help slow the progression of dementia   Brain atrophy in elderly leads to unintended racism, depression and problem gambling   ABILIFY approved for acute treatment of bipolar I disorder in patients 10 to 17 years old   Visual test could help diagnose dementia   Daytime sleepiness can signal depression or even diabetes   Genes influence impulsive behavior, preceding the development of alcoholism   Bipolar Disorder in Children Difficult to Diagnose   Children who live with relatives may have fewer behavioral problems than those in foster care   Teenage suicides: Study advocates greater family support

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]